Illumina Inc. (ILMN)

302.90
NASDAQ : Health Technology
Prev Close 302.30
Day Low/High 302.09 / 305.11
52 Wk Low/High 268.62 / 380.76
Avg Volume 1.08M
Exchange NASDAQ
Shares Outstanding 147.00M
Market Cap 44.44B
EPS 5.60
P/E Ratio 52.85
Div & Yield N.A. (N.A)

Latest News

These Intriguing ETFs Are on the Cutting Edge of Disruptive Technologies

These Intriguing ETFs Are on the Cutting Edge of Disruptive Technologies

Ark Invest has developed a series of specialized exchange-traded funds that own shares in companies involved in 'disruptive innovation.'

5 Attractive Ways to Invest in Oncology

5 Attractive Ways to Invest in Oncology

Experts offer their top stock ideas in oncology detection and treatment.

Illumina Could Rally to Break Its Downtrend

Illumina Could Rally to Break Its Downtrend

Here's how we would play ILMN stock right now.

Jim Cramer: Know Which Way the Wind Blows Before You Pick Stocks

Jim Cramer: Know Which Way the Wind Blows Before You Pick Stocks

PepsiCo, GE and just like the weather, the stock market is subject to change.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Jim Cramer: Valuations Now Have No Relation to Common Sense

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

It is all about perception, and here are strong names to pick up on market weakness.

Illumina's Pullback Looks Like a Buying Opportunity for Further Gain

Illumina's Pullback Looks Like a Buying Opportunity for Further Gain

Look for gains in Illumina shares to $300 and then perhaps around $340.

Consider Going Long Illumina

Consider Going Long Illumina

Illumina could offer a profitable sequence.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

Jim Cramer: Follow the Bouncing Equities

Jim Cramer: Follow the Bouncing Equities

Markets start day with a bungee jump.

Square Is One of 4 Upset Picks in Our Latest 'Sweet 16' Stock Selections

Square Is One of 4 Upset Picks in Our Latest 'Sweet 16' Stock Selections

Watch for these upstart names to topple some big-caps going forward.

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

It's hard to understand the magnitude of the change.

Cramer: Lessons From the Market and ICR

Cramer: Lessons From the Market and ICR

You can make a case to buy any of the stocks of the companies at ICR.

Six Off the Beaten Path Healthcare Stock Gems

Six Off the Beaten Path Healthcare Stock Gems

These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.

Illumina Lights the Way for Biotechs

Illumina Lights the Way for Biotechs

Today's breakout move in the stock is a highlight of the surging sector.

Illumina Lights the Way for Biotechs

Illumina Lights the Way for Biotechs

Today's breakout move in the stock is a highlight of the surging sector.

Trader's Daily Notebook: Anemic Trading Would Be an Improvement

Trader's Daily Notebook: Anemic Trading Would Be an Improvement

Slow markets like this demand a less-is-more approach.

Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

It's a wonder to me how split this market really is.

Nike, Apple, Illumina and Facebook Take Last 4 Spots in TheStreet's Market Bracket Challenge

Nike, Apple, Illumina and Facebook Take Last 4 Spots in TheStreet's Market Bracket Challenge

Nike, Apple, Illumina and Facebook take the last four spots in TheStreet's Market Bracket Challenge.

Illumina upgraded at Leerink

Does Illumina Have the Genes for Lasting Growth?

Does Illumina Have the Genes for Lasting Growth?

This week's introduction of the NovaSeq Series of genomic sequencers caused the stock to jump.

Illumina: The Bears Have Taken Control

Illumina: The Bears Have Taken Control

Considering the major top formation, don't get in their way.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Technology stocks dominate the bearish ledger this week.

Trader's Daily Notebook: You Might Consider Selling Facebook

Trader's Daily Notebook: You Might Consider Selling Facebook

Do that if you like top ticking crowd favorites, but set a protective stop.

Avoid Twitter Like the Plague; It's Uninvestable

Avoid Twitter Like the Plague; It's Uninvestable

If Twitter puts up a dreadful quarter, shares will sell off again.